Abrupt PEPFAR withdrawal from South Africa would endanger lives

Recent disruptions to PEPFAR-supported programs have already led to staff losses and interruptions in patient care.

An MSF team goes to work in Tshwane, South Africa.

An MSF team goes to work in Tshwane. | South Africa 2023 © Bafana Ngwenya/MSF

The reported US government decision to withdraw all PEPFAR funding from South Africa would seriously disrupt HIV prevention and treatment services, particularly for people who already face barriers to accessing care, Doctors Without Borders/Médecins Sans Frontières (MSF) warned today. 

On June 21, South Africa’s National Department of Health issued a statement responding to media reports that the US government would withdraw all PEPFAR funding from the country. 

South Africa has the world’s largest HIV epidemic, with around 8 million people living with HIV. Recent disruptions to PEPFAR-supported programs have already led to the loss of staff, interruptions in patients’ follow-up care, and the closure of community-based organizations that many vulnerable groups rely on. 

A PEPFAR withdrawal will endanger lives

“MSF has been working in HIV care in South Africa since 2001, when we fought for lifesaving treatments to reach people who needed them, especially in communities like Khayelitsha [a township in Cape Town],” stated Antonio Flores, senior HIV and tuberculosis (TB) advisor with MSF’s Southern Africa Medical Unit.

Suddenly withdrawing PEPFAR funding that supports prevention and treatment efforts is a decision clearly not based on science or public health needs.

Antonio Flores, senior HIV and tuberculosis (TB) advisor with MSF’s Southern Africa Medical Unit

“Today, despite huge progress, South Africa still has the largest HIV epidemic in the world,” Flores added. “Suddenly withdrawing PEPFAR funding that supports prevention and treatment efforts is a decision clearly not based on science or public health needs. Instead of a responsible, planned, and phased transition, this abrupt withdrawal risks undermining the support systems that decades of investment helped build. People who find it difficult to access the formal health system because of stigma or discrimination are likely to be most severely affected by this sudden termination. Ultimately, this will endanger lives.” 

An MSF staff does vaccine outreach in Chad. Chad 2025 © Léa Gillabert/MSF

Global health at risk as funding cuts threaten fight against AIDS, TB, and malaria

MSF is already witnessing deadly consequences as vital global health funders withdraw from places where we work.

Read more

MSF has provided HIV care in South Africa for more than two decades. In 2001, MSF launched a pilot HIV treatment program in Khayelitsha, to provide lifesaving antiretrovirals (ARVs). 

South Africa’s Department of Health has long run its own ARV program, procuring about 90 percent of its own ARVs. PEPFAR has supported other HIV services in 27 of the country’s 52 districts. 

Funding and staffing shortfalls will have drastic consequences

MSF is concerned that a sudden withdrawal of PEPFAR funding could deepen disruptions already seen over the last 18 months. Disruptions to PEPFAR-supported activities in South Africa have led to interruptions in treatment and the closure of community-based organizations critical to reaching those least likely to access care. More than 8,000 PEPFAR-funded workers have been laid off, including nearly half of all counselors and data capturers nationwide. Clinics have also faced immediate breakdowns in patient tracking, HIV testing, medication distribution, TB follow-up, and procurement planning. 

Modeling estimates suggest that ending PEPFAR-funded activities in South Africa could result in 150,000 to 296,000 new HIV infections (a 29 to 56 percent increase) and 56,000 to 65,000 additional AIDS-related deaths (a 33 to 38 percent increase) between 2025 and 2028. These developments also come as the Global Fund to Fight AIDS, Tuberculosis and Malaria plans to cut HIV funding allocation to South Africa by 25 percent.